Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors

Avichai Shimoni*, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Arnon Nagler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors'. Together they form a unique fingerprint.

Medicine & Life Sciences